Drugs / Gambrosol trio 40
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00794326 | Oct 2008 → Dec 2014 | chronic renal failure syndrome | Fresenius Medical Care Deutschland GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gambrosol trio 40 | “The aim of this study is to assess the superiority of the new low sodium peritoneal dialysis (PD) solution PDsol 12 in comparison with a conventional, already marketed...” NCT00794326 ↗ |
| Route | Other | “Treatment with the peritoneal dialysis solution Gambrosol trio 40 isotonic bag (1.5%)” NCT00794326 ↗ |